|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT01015092 |
|
Date of registration:
|
16/11/2009 |
|
Primary sponsor: |
|
|
Public title:
|
Cardiovascular Risk Evaluation and Antiretrovirals in HIV
CREATE1 |
|
Scientific title:
|
Predicted 10-year Coronary Heart Disease Risk in HIV and Implications for Clinical Management: the CREATE Study |
|
Date of first enrolment:
|
June 2005 |
|
Target sample size:
|
1024 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT01015092 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Cohort, Time Perspective: Cross-Sectional
|
|
|
Countries of recruitment
|
|
United Kingdom
| | | | | | | |
|
Contacts
|
|
Name:
|
Barry S Peters, MB BS. MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Kings College London |
| | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Serologically proven HIV infection
- Attending general HIV outpatient clinic
Exclusion Criteria:
- Attending a specialist outpatient clinic which might lead to recruitment bias
Age minimum:
18 Years
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Cardiovascular Risk
|
|
HIV Infections
|
|
Primary Outcome(s)
|
|
10 year predicted cardiovascular risk
[Time Frame: AT time of clinic attendence]
|
|
Secondary Outcome(s)
|
|
coronary heart disease risk
[Time Frame: at time of clinic attendence]
|
|
Secondary ID(s)
|
|
05/Q0702/156
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|